Skip to main content
SB

Spark Biomedical

Spark Biomedical, Inc. develops Sparrow Ascent, a wearable transcutaneous nerve field stimulator that provides drug-free relief from opioid withdrawal symptoms. This FDA-cleared device offers significant symptom relief within 30 minutes, enabling patients to undergo treatment without the need for prior withdrawal or systemic side effects.

Houston, United StatesFounded 2018345K+ followers
Updated 20 months ago

Funding

$19.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

NI
Funding rounds are not available yet.

Founders

Product

Problem

Opioid withdrawal is a significant barrier to recovery, often requiring patients to undergo a period of intense discomfort before treatment can begin, leading to poor adherence and relapse. Existing treatments may have systemic side effects or drug interactions, further complicating the withdrawal process.

Solution

Spark Biomedical's Sparrow Ascent is a wearable, transcutaneous nerve field stimulator that provides drug-free relief from opioid withdrawal symptoms. The device is FDA-cleared and delivers significant symptom reduction, often within 30 minutes, without the need for prior withdrawal or systemic medications. This allows patients to initiate and continue treatment without the limitations of traditional withdrawal management protocols. Clinical studies have demonstrated that the majority of patients experience mild to no withdrawal symptoms after one hour of therapy, with sustained reduction in symptoms by day three.

Target Audience

The primary audience includes patients experiencing opioid withdrawal, physicians managing opioid withdrawal, and treatment centers focused on substance use disorder recovery.

Features

  • Wearable transcutaneous nerve field stimulator designed for opioid withdrawal symptom relief
  • FDA-cleared for use in conjunction with standard symptomatic medication and other therapies
  • Provides significant symptom relief within 30 minutes of application
  • Non-addictive and drug-free, eliminating concerns about drug interactions and systemic side effects
  • Can be used in various settings, offering flexibility in treatment location and duration
  • Demonstrated high rates of acceptance to continued substance use disorder treatment post-detox
This profile is AI-generated and may contain inaccuracies.